
European Small Molecule Manufacturing at Critical Juncture as Green Rules Meet Market Reality
At CDMO Live 2025, industry leaders Elisabeth Stampa (Medicines for Europe), Elena Barboni (Flamma) and Agneta Larhed (RegSmart Life Science) discussed how Europe's stringent new regulations could reshape the continent's pharmaceutical manufacturing landscape.
Europe's pharmaceutical manufacturing sector faces an unprecedented challenge as new environmental regulations threaten to drive production offshore, whilst the Critical Medicines Act attempts to bring it back home. Industry leaders warn that razor-thin margins on generic medicines could lead to widespread product withdrawals if costs aren't carefully managed.
D'autres épisodes de "PharmaSource Podcast"
Ne ratez aucun épisode de “PharmaSource Podcast” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.